63.77USD-1.28%Mkt Cap: 2.16B USDP/E: —Last update: 2026-06-01
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap2.16B USD
Enterprise Value1.18B USD
Revenue (TTM)55.63M USD
Gross Profit55.23M USD
Net Income (TTM)-164.08M USD
Revenue/Share2.847 USD
Last Price63.77 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees63
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6402681083
Valuation
P/E (Trailing)—
P/E (Forward)-5.16
PEG0.31
EV/EBITDA-9.53
EV/Revenue21.21
P/S39.40
P/B2.79
EPS (TTM)-7.93
EPS (Forward)-12.56
52W Range
7.99055% of range109.00
52W High109.00 USD
52W Low7.990 USD
Profitability
Gross Margin100.00%
Oper. Margin-352.25%
EBITDA Margin-222.54%
Profit Margin-297.07%
ROE-182.65%
ROA-58.51%
Growth
Revenue Growth3.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-208.51M USD
CapEx (TTM)171.00K USD
FCF Margin—
FCF Yield—
Net Debt-425.17M USD
Net Debt/EBITDA3.43
Balance Sheet
Debt/Equity0.95
Current Ratio10.21
Quick Ratio9.85
Book Value/Sh23.30 USD
Cash/Share22.99 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateJun 9, 2025
Analyst Consensus
Rating—
Target (Mean)153.25 USD
Target Range80.00 USD – 192.00 USD
# Analysts8
Ownership
Shares Out.33.79M
Float21.31M
Insiders0.45%
Institutions79.97%
Short Interest
Short Ratio3.5d
Short % Float14.27%
Short % Out.12.93%
Shares Short4.37M
Short (prev mo.)3.63M
Technical
SMA 5078.01 (-18.2%)
SMA 20058.33 (+9.3%)
Beta1.25
S&P 52W Chg27.94%
Avg Vol (30d)1.14M
Avg Vol (10d)901.95K
Technical Indicators
RSI (14)30.2
MACD-4.5179
MACD Signal-3.3528
MACD Hist.-1.1651
BB Upper90.58 USD
BB Middle74.33 USD
BB Lower58.09 USD
BB Width43.71%
ATR (14)3.658 USD
Vol Ratio (20d)0.75x